Copyright Reports & Markets. All rights reserved.

Global Cytotoxic Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Cytotoxic Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Cytotoxic Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cytotoxic Drugs Market Size Growth Rate by Type
    • 1.4.2 Alkylating Agents
    • 1.4.3 Antitumor Antibiotics
    • 1.4.4 Antimetabolites
    • 1.4.5 Plant Alkaloids
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Cytotoxic Drugs Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Cancer Research Center
    • 1.5.4 Drug Testing Laboratory
    • 1.5.5 CDMOs
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Cytotoxic Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Cytotoxic Drugs Revenue 2015-2026
    • 2.1.2 Global Cytotoxic Drugs Sales 2015-2026
  • 2.2 Global Cytotoxic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Cytotoxic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Cytotoxic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Cytotoxic Drugs Competitor Landscape by Players

  • 3.1 Cytotoxic Drugs Sales by Manufacturers
    • 3.1.1 Cytotoxic Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Cytotoxic Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Cytotoxic Drugs Revenue by Manufacturers
    • 3.2.1 Cytotoxic Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Cytotoxic Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Cytotoxic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Cytotoxic Drugs Revenue in 2019
    • 3.2.5 Global Cytotoxic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Cytotoxic Drugs Price by Manufacturers
  • 3.4 Cytotoxic Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Cytotoxic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Cytotoxic Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Cytotoxic Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Cytotoxic Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Cytotoxic Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Cytotoxic Drugs Revenue by Type (2015-2020)
    • 4.1.3 Cytotoxic Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Cytotoxic Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Cytotoxic Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Cytotoxic Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Cytotoxic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Cytotoxic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Cytotoxic Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Cytotoxic Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Cytotoxic Drugs Revenue by Application (2015-2020)
    • 5.1.3 Cytotoxic Drugs Price by Application (2015-2020)
  • 5.2 Cytotoxic Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Cytotoxic Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Cytotoxic Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Cytotoxic Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Cytotoxic Drugs by Country
    • 6.1.1 North America Cytotoxic Drugs Sales by Country
    • 6.1.2 North America Cytotoxic Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Cytotoxic Drugs Market Facts & Figures by Type
  • 6.3 North America Cytotoxic Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Cytotoxic Drugs by Country
    • 7.1.1 Europe Cytotoxic Drugs Sales by Country
    • 7.1.2 Europe Cytotoxic Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Cytotoxic Drugs Market Facts & Figures by Type
  • 7.3 Europe Cytotoxic Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Cytotoxic Drugs by Region
    • 8.1.1 Asia Pacific Cytotoxic Drugs Sales by Region
    • 8.1.2 Asia Pacific Cytotoxic Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Cytotoxic Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Cytotoxic Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Cytotoxic Drugs by Country
    • 9.1.1 Latin America Cytotoxic Drugs Sales by Country
    • 9.1.2 Latin America Cytotoxic Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Cytotoxic Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Cytotoxic Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Cytotoxic Drugs by Country
    • 10.1.1 Middle East and Africa Cytotoxic Drugs Sales by Country
    • 10.1.2 Middle East and Africa Cytotoxic Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Cytotoxic Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Cytotoxic Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 CytoPharma
    • 11.1.1 CytoPharma Corporation Information
    • 11.1.2 CytoPharma Description and Business Overview
    • 11.1.3 CytoPharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 CytoPharma Cytotoxic Drugs Products Offered
    • 11.1.5 CytoPharma Related Developments
  • 11.2 Bristol-Myers Squibb
    • 11.2.1 Bristol-Myers Squibb Corporation Information
    • 11.2.2 Bristol-Myers Squibb Description and Business Overview
    • 11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Bristol-Myers Squibb Cytotoxic Drugs Products Offered
    • 11.2.5 Bristol-Myers Squibb Related Developments
  • 11.3 Amgen
    • 11.3.1 Amgen Corporation Information
    • 11.3.2 Amgen Description and Business Overview
    • 11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Amgen Cytotoxic Drugs Products Offered
    • 11.3.5 Amgen Related Developments
  • 11.4 Celgene Corp
    • 11.4.1 Celgene Corp Corporation Information
    • 11.4.2 Celgene Corp Description and Business Overview
    • 11.4.3 Celgene Corp Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Celgene Corp Cytotoxic Drugs Products Offered
    • 11.4.5 Celgene Corp Related Developments
  • 11.5 Eli Lilly and Company
    • 11.5.1 Eli Lilly and Company Corporation Information
    • 11.5.2 Eli Lilly and Company Description and Business Overview
    • 11.5.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Eli Lilly and Company Cytotoxic Drugs Products Offered
    • 11.5.5 Eli Lilly and Company Related Developments
  • 11.6 F. Hoffmann-La Roche
    • 11.6.1 F. Hoffmann-La Roche Corporation Information
    • 11.6.2 F. Hoffmann-La Roche Description and Business Overview
    • 11.6.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 F. Hoffmann-La Roche Cytotoxic Drugs Products Offered
    • 11.6.5 F. Hoffmann-La Roche Related Developments
  • 11.7 GlaxoSmithKline PLC
    • 11.7.1 GlaxoSmithKline PLC Corporation Information
    • 11.7.2 GlaxoSmithKline PLC Description and Business Overview
    • 11.7.3 GlaxoSmithKline PLC Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 GlaxoSmithKline PLC Cytotoxic Drugs Products Offered
    • 11.7.5 GlaxoSmithKline PLC Related Developments
  • 11.8 Johnson and Johnson
    • 11.8.1 Johnson and Johnson Corporation Information
    • 11.8.2 Johnson and Johnson Description and Business Overview
    • 11.8.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Johnson and Johnson Cytotoxic Drugs Products Offered
    • 11.8.5 Johnson and Johnson Related Developments
  • 11.9 Lonza
    • 11.9.1 Lonza Corporation Information
    • 11.9.2 Lonza Description and Business Overview
    • 11.9.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Lonza Cytotoxic Drugs Products Offered
    • 11.9.5 Lonza Related Developments
  • 11.10 Merck
    • 11.10.1 Merck Corporation Information
    • 11.10.2 Merck Description and Business Overview
    • 11.10.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Merck Cytotoxic Drugs Products Offered
    • 11.10.5 Merck Related Developments
  • 11.1 CytoPharma
    • 11.1.1 CytoPharma Corporation Information
    • 11.1.2 CytoPharma Description and Business Overview
    • 11.1.3 CytoPharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 CytoPharma Cytotoxic Drugs Products Offered
    • 11.1.5 CytoPharma Related Developments
  • 11.12 Pfizer
    • 11.12.1 Pfizer Corporation Information
    • 11.12.2 Pfizer Description and Business Overview
    • 11.12.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Pfizer Products Offered
    • 11.12.5 Pfizer Related Developments
  • 11.13 Sanofi
    • 11.13.1 Sanofi Corporation Information
    • 11.13.2 Sanofi Description and Business Overview
    • 11.13.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Sanofi Products Offered
    • 11.13.5 Sanofi Related Developments
  • 11.14 Teva Pharmaceutical
    • 11.14.1 Teva Pharmaceutical Corporation Information
    • 11.14.2 Teva Pharmaceutical Description and Business Overview
    • 11.14.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Teva Pharmaceutical Products Offered
    • 11.14.5 Teva Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Cytotoxic Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Cytotoxic Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Cytotoxic Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Cytotoxic Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Cytotoxic Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Cytotoxic Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Cytotoxic Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Cytotoxic Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Cytotoxic Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Cytotoxic Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Cytotoxic Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Cytotoxic Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Cytotoxic Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Cytotoxic Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Cytotoxic Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Cytotoxic Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Cytotoxic Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Cytotoxic Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Cytotoxic Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Cytotoxic Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Cytotoxic Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Cytotoxic Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Cytotoxic Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Cytotoxic Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Cytotoxic Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Cytotoxic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cytotoxic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Cytotoxic Drugs market is segmented into
    Alkylating Agents
    Antitumor Antibiotics
    Antimetabolites
    Plant Alkaloids
    Others

    Segment by Application, the Cytotoxic Drugs market is segmented into
    Hospital
    Cancer Research Center
    Drug Testing Laboratory
    CDMOs

    Regional and Country-level Analysis
    The Cytotoxic Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Cytotoxic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Cytotoxic Drugs Market Share Analysis
    Cytotoxic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cytotoxic Drugs business, the date to enter into the Cytotoxic Drugs market, Cytotoxic Drugs product introduction, recent developments, etc.

    The major vendors covered:
    CytoPharma
    Bristol-Myers Squibb
    Amgen
    Celgene Corp
    Eli Lilly and Company
    F. Hoffmann-La Roche
    GlaxoSmithKline PLC
    Johnson and Johnson
    Lonza
    Merck
    Novartis
    Pfizer
    Sanofi
    Teva Pharmaceutical

    Buy now